Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3895
Revised: September 28, 2024
Accepted: October 31, 2024
Published online: December 27, 2024
Processing time: 113 Days and 19.3 Hours
The number of lymph nodes (LNs) dissected during surgery has become an interesting topic. Simple intuition always leads us to believe that dissecting more LNs will result in more accurate pathological staging and assurance of surgical quality. However, when the number of LNs dissected reaches a certain threshold, the patient’s prognosis does not continue to improve as the number of dissected nodes increases. Instead, an increase in the number of dissected LNs may be accompanied by a higher incidence of complications. Currently, there are only less than 40% of colorectal cancer patients undergoing adequate LN evaluation. Therefore, obtaining a sufficient number of LNs in clinical practice is extremely challenging. How to further address the insufficiency of LN dissection due to various reasons, which results in concerns of surgeons about patient prognosis, is currently a critical focus.
Core Tip: Much as obtaining a sufficient number of lymph nodes (LNs) is extremely important for determining the postoperative pathological stage and postoperative intervention treatment and improving the prognosis of colorectal cancer (CRC) patients, it remains a major challenge in clinical practice. The study by He et al confirmed no correlation between the number of LNs dissected in stage I-II CRC and overall survival, which alleviates the concerns of surgeons about insufficient LN dissection and its impact on patient prognosis. However, due to the limitations of this study, more studies are needed to validate the results.